Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Virginia E. Kwitkowski | Researchclopedia

Back to researchers

Virginia E. Kwitkowski

United States Food and Drug Administration

24

Works

2,452

Citations

20

h-index

21

i10-index

Research Topics

Lymphoma Diagnosis and Treatment Health Systems, Economic Evaluations, Quality of Life Acute Lymphoblastic Leukemia research

Affiliations

National Institutes of Health2006–2008

United States Food and Drug Administration2010–2020

Center for Drug Evaluation and Research2010–2020

National Cancer Institute2004–2008

Center for Cancer Research2004–2008

Top Works

FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma

Hyon-Zu Lee,Virginia E. Kwitkowski,et al.

2015348 citations

Chronic Lymphocytic Leukemia Research

Cancer Genomics and Diagnostics

Combination Targeted Therapy With Sorafenib and Bevacizumab Results in Enhanced Toxicity and Antitumor Activity

Nilofer S. Azad,Edwin M. Posadas,et al.

2008337 citations

Focusing on Core Patient-Reported Outcomes in Cancer Clinical Trials: Symptomatic Adverse Events, Physical Function, and Disease-Related Symptoms

Paul G. Kluetz,Ashley F. Slagle,et al.

2016318 citations

FDA Approval Summary: Temsirolimus as Treatment for Advanced Renal Cell Carcinoma

Virginia E. Kwitkowski,Tatiana M. Prowell,et al.

2010243 citations

U.S. Food and Drug Administration Approval Summary: Brentuximab Vedotin for the Treatment of Relapsed Hodgkin Lymphoma or Relapsed Systemic Anaplastic Large-Cell Lymphoma

R. Angelo de Claro,Karen M. McGinn,et al.

2012207 citations

PCN122 DEVELOPMENT OF THE PATIENT-REPORTED VERSION OF THE COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS (PRO-CTCAE)

Ethan Basch,Bryce B. Reeve,et al.

2010163 citations

A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer

Edwin M. Posadas,Meghan S. Liel,et al.

2007143 citations

Reducing the toxicity of cancer therapy: recognizing needs, taking action

Charles S. Cleeland,Jeff Allen,et al.

2012129 citations

U.S. Food and Drug Administration Approval Summary: Omacetaxine Mepesuccinate as Treatment for Chronic Myeloid Leukemia

Firoozeh Alvandi,Virginia E. Kwitkowski,et al.

201397 citations